APUS

Apimeds Pharmaceuticals US, Inc AMEX Listed May 9, 2025

Healthcare ·Drug Manufacturers - Specialty & Generic ·US · apimedsus.com

$1.47

Mkt Cap $1.8M

52w Low $1.38 0.2% of range 52w High $40.31

50d MA $7.53 200d MA $16.32

P/E (TTM) -1.6x

EV/EBITDA -2.5x

P/B —

Debt/Equity -0.4x

ROE -34.8%

P/FCF -3.5x

RSI (14) —

ATR (14) —

Beta -1.37

50d MA $7.53

200d MA $16.32

Avg Volume 22.5K

Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey. Apimeds Pharmaceuticals US, Inc. is a subsidiary of Api Meds, Inc.

SIC Code

2834

CIK (SEC)

1894525

Phone

808-209-7887

2 East Broad Street · Hopewell, NJ 08525 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Nov 12, 2025	AMC	—	-0.14	—	2.68	+6.3%	+4.1%	+19.8%	+45.5%	+14.9%	+13.1%	—
Aug 19, 2025	AMC	—	-0.26	—	1.90	-0.5%	-4.7%	+19.5%	+15.8%	+1.6%	-1.1%	—
May 19, 2025	AMC	—	-0.05	—	1.79	+1.1%	+3.4%	+0.6%	+1.7%	+1.1%	+0.6%	—
Dec 31, 2024	AMC	—	-0.02	—	—	—	—	—	—	—	—	—
Sep 30, 2024	AMC	—	-0.03	—	—	—	—	—	—	—	—	—
Jun 30, 2024	AMC	—	-0.04	—	—	—	—	—	—	—	—	—
Mar 31, 2024	AMC	—	-0.02	—	—	—	—	—	—	—	—	—
Dec 31, 2023	AMC	—	-0.04	—	—	—	—	—	—	—	—	—
Sep 30, 2023	AMC	—	-0.01	—	—	—	—	—	—	—	—	—
Jun 30, 2023	AMC	—	-0.00	—	—	—	—	—	—	—	—	—
Mar 31, 2023	AMC	—	-0.01	—	—	—	—	—	—	—	—	—
Dec 31, 2022	AMC	—	-0.01	—	—	—	—	—	—	—	—	—

Data updated apr 24, 2026 6:36pm · Source: massive.com